137 results on '"van Laar, Teus"'
Search Results
2. The Effectiveness of Inpatient Rehabilitation in Parkinson’s Disease: A Systematic Review of Recent Studies
3. Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
4. Short-latency afferent inhibition as a biomarker of cholinergic degeneration compared to PET imaging in Parkinson's disease
5. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
6. Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease
7. Objective clinical registration of tremor, bradykinesia, and rigidity during awake stereotactic neurosurgery: a scoping review
8. Reading Difficulties in Parkinson’s Disease: A Stepped Care Model for Neurovisual Rehabilitation
9. Cholinergic innervation topography in GBA-associated de novo Parkinson’s disease patients
10. The Relevance of Intraoperative Clinical and Accelerometric Measurements for Thalamotomy Outcome
11. Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease
12. Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review
13. Infusion Therapies in the Treatment of Parkinson’s Disease
14. Impaired facial emotion recognition in relation to social behaviours in de novo Parkinson's disease
15. A Novel Accelerometry Method to Perioperatively Quantify Essential Tremor Based on Fahn–Tolosa–Marin Criteria
16. Supine MDS-UPDRS-III Assessment: An Explorative Study
17. Combined multidisciplinary in/outpatient rehabilitation delays definite nursing home admission in advanced Parkinson’s disease patients
18. Prevalence and nature of self-reported visual complaints in people with Parkinson’s disease—Outcome of the Screening Visual Complaints questionnaire
19. Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool
20. Visual Hallucinations in Psychosis: The Curious Absence of the Primary Visual Cortex
21. The Intraoperative Microlesion Effect Positively Correlates With the Short-Term Clinical Effect of Deep Brain Stimulation in Parkinson's Disease
22. Cholinesterase Inhibitors for Psychotic Symptoms in Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies: An Individual Participant Data Meta-Analysis
23. Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s Disease
24. Striatal Dopaminergic Asymmetry as a marker of Brain-First and Body-First Subtypes in de novo Parkinson’s Disease
25. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson’s disease—Confirmatory factor analysis and advice for its use in clinical practice
26. Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach
27. Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease
28. STN-DBS electrode placement accuracy and motor improvement in Parkinson’s disease: systematic review and individual patient meta-analysis
29. The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson’s disease—Confirmatory factor analysis and advice for its use in clinical practice
30. Impaired functional connectivity in patients with psychosis and visual hallucinations
31. Impaired visual processing in psychosis patients with a predisposition for visual hallucinations
32. Intraoperative Quantification of MDS-UPDRS Tremor Measurements Using 3D Accelerometry: A Pilot Study
33. Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review
34. Letter to the editor, “Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications”
35. No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson’s Disease
36. Diepe hersenstimulatie bij de ziekte van Parkinson
37. Gut microbiome alterations in fecal samples of treatment-naïve de novo Parkinson’s disease patients
38. Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment
39. Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study
40. Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants
41. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology
42. Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry
43. Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gait
44. Treatment of subcutaneous nodules after infusion of apomorphine; a biopsy-controlled study comparing 4 frequently used therapies
45. Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data
46. Timely referral for advanced therapy in Parkinson’s disease. Development of a screening tool
47. Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
48. Acute effects of adaptive Deep Brain Stimulation in Parkinson’s disease
49. Pre-Movement Cortico-Muscular Dynamics Underlying Improved Parkinson Gait Initiation after Instructed Arm Swing
50. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.